The role of the kynurenine pathway in suicidality in adolescent major depressive disorder

Psychiatry Research

Volumn 227, Issue 2-3, 2015, Pages 206-212

  Bradley, Kailyn A L ^a   Case, Julia A C ^a   Khan, Omar ^a   Ricart, Thomas ^a   Hanna, Amira ^a   Alonso, Carmen M ^b   Gabbay, Vilma ^a,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

3 dioxygenase; 3 hydroxyanthranilic acid; Adolescence; Depression; Indoleamine 2; Suicide; Tryptophan

Indexed keywords

3 HYDROXYANTHRANILIC ACID; AMFEBUTAMONE; AMPHETAMINE DERIVATIVE; CITALOPRAM; FLUOXETINE; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; LAMOTRIGINE; LITHIUM; METHYLPHENIDATE; MIRTAZAPINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SERTRALINE; TRYPTOPHAN; BIOLOGICAL MARKER;

ADOLESCENT; AMINO ACID BLOOD LEVEL; ANHEDONIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; JUVENILE; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE ATTEMPT; BLOOD; SUICIDE;

ADOLESCENT; ANHEDONIA; BIOMARKERS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; KYNURENINE; MALE; SUICIDE; SUICIDE, ATTEMPTED; TRYPTOPHAN;

EID: 84929132678     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2015.03.031     Document Type: Article

References (42)

1. Almeida-Montes L.G., Valles-Sanchez V., Moreno-Aguilar J., Chavez-Balderas R.A., Garcia-Marin J.A., Cortés Sotres J.F., Hheinze-Martin G. Relation of serum cholesterol, lipid, serotonin and tryptophan levels to severity of depression and to suicide attempts. Journal of Psychiatry & Neuroscience 2000, 25:371-377.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Washington, DC, text rev. 4th ed.
3. Bay-Richter C., Linderholm K.R., Lim C.K., Samuelsson M., Träskman-Bendz L., Guillemin G.J., Erhardt S., Brundin L. A role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality. Brain, Behavior, and Immunity 2015, 43:110-117.
4. Brent D.A., Perper J.A., Moritz G., Allman C., Friend A., Roth C., Schweers J., Balach L., Baugher M. Psychiatric risk factors of adolescent suicide: a case control study. Journal of the American Academy of Child & Adolescent Psychiatry 1993, 32:521-529.
5. Brown G.K., Beck A.T., Steer R.A., Grisham J.R. Risk factors for suicide in psychiatric outpatients: a 20-year prospective study. Journal of Consulting and Clinical Psychology 2000, 68:371-377.
6. Clark D.B. Serum tryptophan ratio and suicidal behavior in adolescents: a prospective study. Psychiatry Research 2003, 119:199-204.
7. Curzon G., Bridges P.K. Tryptophan metabolism in depression. Journal of Neurology, Neurosurgery & Psychiatry 1970, 33:698-704.
8. Erhardt S., Lim C.K., Linderholm K.R., Janelidze S., Lindqvist D., Samuelsson M., Lundberg K., Postolache T.T., Träskman-Bendz L., Guillemin G.J., Brundin L. Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacology 2013, 38:743-752.
9. Gabbay V., Ely B.A., Babb J., Liebes L. The possible role of the kynurenine pathway in anhedonia in adolescents. Journal of Neural Transmission 2012, 119:253-260.
10. Gabbay V., Johnson A.R., Alonso C.M., Evans L.K., Babb J.S., Klein R.G. Anhedonia but not irritability is associated with illness severity outcomes in adolescent major depression. Journal of Child and Adolescent Psychopharmacology 2015, in press.
11. Gabbay V., Klein R.G., Guttman L.E., Babb J.S., Alonso C.M., Nishawala M., Katz Y., Gaite M.R., Gonzalez C.J. A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression. Journal of Child and Adolescent Psychopharmacology 2009, 19:423-430.
12. Gabbay V., Klein R.G., Katz Y., Mendoza S., Guttman L.E., Alonso C.M., Babb J.S., Hirsch G.S., Liebes L. The possible role of the kynurenine pathway in adolescent depression with melancholic features. Journal of Child Psychology and Psychiatry 2010, 51:935-943.
13. Gabbay V., Liebes L., Katz Y., Liu S., Mendoza S., Babb J.S., Klein R.G., Gonen O. The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2010, 34:37-44.
14. Henry C.J., Huang Y., Wynne A., Hanke M., Himler J., Bailey M.T., Sheridan J.F., Godbout J.P. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. Journal of Neuroinflammation 2008, 5:15-28.
15. Heyes M.P., Ellis R.J., Ryan L., Childers M.E., Grant I., Wolfson T., Archibald S., Jernigan T.L. Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection. Brain 2001, 124:1033-1042.
16. Heyes M.P., Saito K., Crowley J.S., Davis L.E., Demitrack M.A., Der M., Dilling L.A., Elia J., Kruesi M.J.P., Lackner A., Larsen S.A., Lee K., Leonard H.L., Markey S.P., Martin A., Milstein S., Mouradian M.M., Pranzatelli M.R., Quearry B.J., Salazar A., Smith M., Strauss S.E., Sunderland T., Swedo S.W., Tourtellotte W.W. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 1992, 115:1249-1273.
17. Kaufman J., Birmaher B., Brent D., Rao U., Flynn C., Moreci P., Williamson D., Ryan N. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. Journal of the American Academy of Child & Adolescent Psychiatry 1997, 36:980-988.
18. Kostadinov I.D., Delev D.P., Murdjeva M.A., Kostadinova I.I. Experimental study on the role of 5-HT2 serotonin receptors in the mechanism of anti-inflammatory and antihyperalgesic action of antidepressant fluoxetine. Folia Medica 2014, 56:43-49.
19. Laugeray L., Launay J.M., Callebert J., Surget A., Belzung C., Barone P.R. Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression. Behavioural Brain Research 2010, 210:84-91.
20. Lewinsohn P.M., Rohde P., Seeley J.R. Psychosocial risk factors for future adolescent suicide attempts. Journal of Consulting and Clinical Psychology 1994, 62:297-305.
21. Linkswiler H. Biochemical and physiological changes in vitamin B6 deficiency. The American Journal of Clinical Nutrition 1967, 20:547-557.
22. Liu R.P., Zou M., Wang J.Y., Zhu J.J., Lai J.M., Zhou L.L., Chen S.F., Zhang X., Zhu J.H. Paroxetine ameliorates lipopolysaccharide-induced microglia activation via differential regulation of MAPK signaling. Journal of Neuroinflammation 2014, 11:47-57.
23. Maes M., Scharpé S., Meltzer H.Y., Okayli G., Bosmans E., D'Hondt P., Vanden Bossche B.V., Cosyns P. Increased neopterin and interferon-gamma secretion and lower availability of l-tryptophan in major depression: further evidence for an immune response. Psychiatry Research 1994, 54:143-160.
24. Mann J.J., Malone K.M., Sweeney J.A., Brown R.P., Linnoila M., Stanley B., Stanley M. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients. Neuropsychopharmacology 1996, 15:576-586.
25. Moreau M., André C., O'Connor J.C., Dumich S.A., Woods J.A., Kelley K.W., Dantzer R., Lestage J., Castanon N. Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior. Brain, Behavior, and Immunity 2008, 22:1087-1095.
26. Myint A.M., Kim Y.K. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Medical Hypotheses 2003, 61:519-525.
27. O'Connor J.C., Lawson M.A., André C., Moreau M., Lestage J., Castanon N., Kelley K.W., Dantzer R. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Molecular Psychiatry 2009, 14:511-522.
28. Obuchowicz E., Bielecka A.M., Paul-Samojedny M., Pudełko A., Kowalski J. Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture. Pharmacology Reports 2014, 66:34-43.
29. Okuda S., Nishiyama N., Saito H., Katsuki H. 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. Journal of Neurochemistry 1998, 70:299-307.
30. Oxenkrug G., Turski W., Zgrajka W., Weinstock J., Ruthazer R., Summergrad P. Disturbances of tryptophan metabolism and risk of depression in HCV patients treated with IFN-alpha. Journal of Infectious Diseases & Therapy 2014, 2:131.
31. Perou R., Bitsko R.H., Blumberg S.J., Pastor P., Ghandour R.M., Gfroerer J.C., Hedden S.L., Crosby A.E., Visser S.N., Schieve L.A., Parks S.E., Hall J.E., Brody D., Simile C.M., Thompson W.W., Baio J., Avenevoli S., Kogan M.D., Huang L.N. Mental health surveillance among children-United States, 2005-2011. Morbidity and Mortality Weekly Report 2013, 62:1-35.
32. Pfeffer C.R., Klerman G.L., Hurt S.W., Kakuma T., Peskin J.R., Siefker C.A. Suicidal children grow up: rates and psychosocial risk factors for suicide attempts during follow-up. Journal of the American Academy of Child & Adolescent Psychiatry 1993, 32:106-113.
33. Pfeffer C.R., McBride P.A., Anderson G.M., Kakuma T., Fensterheim L., Khait V. Peripheral serotonin measures in prepubertal psychiatric inpatients and normal children: associations with suicidal behavior and its risk factors. Biological Psychiatry 1998, 44:568-577.
34. Quade D. Rank analysis of covariance. Journal of the American Statistical Association 1967, 62:1187-1200.
35. Quak J., Doornbos B., Roest A.M., Duivis H.E., Vogelzangs N., Nolen W.A., Penninx B.W., Kema I.P., de Jonge P. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?. Psychoneuroendocrinology 2014, 45:202-210.
36. Raison C.L., Dantzer R., Kelley K.W., Lawson M.A., Woolwine B.J., Vogt G., Spivey J.R., Saito K., Miller A.H. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Molecular Psychiatry 2009, 15:393-403.
37. Roggenbach J., Müller-Oerlinghausen B., Franke L., Uebelhack R., Blank S., Ahrens B. Peripheral serotonergic markers in acutely suicidal patients. 1. Comparison of serotonergic platelet measures between suicidal individuals, nonsuicidal patients with major depression and healthy subjects. Journal of Neural Transmission 2007, 114:479-487.
38. Salazar A., Gonzalez-Rivera B.L., Redus L., Parrott J.M., O'Connor J.C. Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Hormones and Behavior 2012, 62:202-209.
39. Shaffer D., Gould M.S., Fisher P., Trautman P., Moreau D., Kleinman M., Flory M. Psychiatric diagnosis in child and adolescent suicide. Archives of General Psychiatry 1996, 53:339-348.
40. Sublette M.E., Galfalvy H.C., Fuchs D., Lapidus M., Grunebaum M.F., Oquendo M.A., Mann J.J., Postolache T.T. Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder. Brain, Behavior, and Immunity 2011, 25:1272-1278.
41. Yess N., Price J.M., Brown R.R., Swan P.B., Linkswiler H. Vitamin B6 depletion in man: urinary excretion of tryptophan metabolites. Journal of Nutrition 1964, 84:229-236.
42. Zhang H., Chen Z., Jia Z., Gong Q. Dysfunction of neural circuitry in depressive patients with suicidal behaviors: a review of structural and functional neuroimaging studies. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2014, 53:61-66.